DENTSPLY SIRONA Inc. Files 8-K on Officer/Director Changes

Ticker: XRAY · Form: 8-K · Filed: 2025-10-03T00:00:00.000Z

Sentiment: neutral

Topics: officer-changes, director-changes, compensation

Related Tickers: XRAY

TL;DR

DENTSPLY SIRONA Inc. (XRAY) filed an 8-K detailing changes in directors/officers and compensation.

AI Summary

DENTSPLY SIRONA Inc. filed an 8-K on October 3, 2025, reporting events as of October 2, 2025. The filing primarily concerns the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. It also includes financial statements and exhibits.

Why It Matters

This filing indicates potential shifts in leadership or executive compensation at DENTSPLY SIRONA Inc., which could impact the company's strategic direction and investor confidence.

Risk Assessment

Risk Level: medium — Changes in directors and officers, especially if related to performance or compensation, can signal underlying issues or strategic shifts that may affect the company's future performance.

Key Players & Entities

FAQ

What specific officers or directors have departed from DENTSPLY SIRONA Inc. as of October 2, 2025?

The filing indicates the 'Departure of Directors or Certain Officers' as an item of information, but does not list specific names in the provided text.

Who has been elected as a new director to the board of DENTSPLY SIRONA Inc.?

The filing lists 'Election of Directors' as an item of information, but the specific names of newly elected directors are not detailed in the provided text.

Were there any new appointments of certain officers at DENTSPLY SIRONA Inc. on or before October 2, 2025?

The filing confirms 'Appointment of Certain Officers' as a reported item, but the specific individuals appointed are not named in the excerpt.

What are the details of the compensatory arrangements for certain officers at DENTSPLY SIRONA Inc.?

The filing includes 'Compensatory Arrangements of Certain Officers' as a reported item, but the specifics of these arrangements are not provided in the given text.

What financial statements or exhibits are included with this 8-K filing?

The filing states that 'Financial Statements and Exhibits' are included, but the specific contents are not detailed in the provided text.

From the Filing

0000818479-25-000182.txt : 20251003 0000818479-25-000182.hdr.sgml : 20251003 20251003161908 ACCESSION NUMBER: 0000818479-25-000182 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 29 CONFORMED PERIOD OF REPORT: 20251002 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20251003 DATE AS OF CHANGE: 20251003 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DENTSPLY SIRONA Inc. CENTRAL INDEX KEY: 0000818479 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 391434669 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-16211 FILM NUMBER: 251374132 BUSINESS ADDRESS: STREET 1: 13320 BALLANTYNE CORPORATE PLACE CITY: CHARLOTTE STATE: NC ZIP: 28277-3607 BUSINESS PHONE: 844-546-3722 MAIL ADDRESS: STREET 1: 13320 BALLANTYNE CORPORATE PLACE CITY: CHARLOTTE STATE: NC ZIP: 28277-3607 FORMER COMPANY: FORMER CONFORMED NAME: DENTSPLY INTERNATIONAL INC /DE/ DATE OF NAME CHANGE: 19930630 FORMER COMPANY: FORMER CONFORMED NAME: GENDEX CORP DATE OF NAME CHANGE: 19920703 8-K 1 xray-20251002.htm 8-K xray-20251002 0000818479 false 0000818479 2025-10-02 2025-10-02 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 October 2, 2025 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 13320 Ballantyne Corporate Place, Charlotte North Carolina 28277-3607 (Address of principal executive offices) (Zip Code) ( 844 ) 848-0137 (Registrant’s telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share XRAY The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On October 2, 2025, DENTSPLY SIRONA Inc. (the “Company”) announced that Richard C. Rosenzweig, Executive Vice President, Corporate Development, General Counsel and Secretary of the Company, will no longer serve in that role by mutual agreement, effective October 3, 2025. Mr. Rosenzweig will serve as a non-executive employee with the title of Special Legal Advisor through March 4, 2026 or his earlier termination (the “Separatio

View on Read The Filing